Premium
Anticholinergics, not beta‐agonists, reduce exacerbations in COPD
Author(s) -
Burrill Peter
Publication year - 2007
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.47
Subject(s) - medicine , copd , beta (programming language) , intensive care medicine , critical appraisal , alternative medicine , pathology , computer science , programming language
A randomised controlled trial published in a peer‐reviewed journal is considered to be the ‘gold standard’ of information about the effectiveness of a treatment; however, critical appraisal of trials is required in order to judge the value and implications of the results. Here, the author presents an appraisal of a study comparing the efficacy of beta‐agonists and anticholinergics in COPD. Salpeter SR, Buckley NS, Salpeter EE. Meta‐analysis: anticholinergics, but not beta‐agonists, reduce severe exacerbations and respiratory mortality in COPD. J Gen Intern Med 2006;21(10):1011‐9. Copyright © 2007 Wiley Interface Ltd